The global thyroid eye disease (TED) market is experiencing growth due to innovative treatment options, enhanced diagnostics, and increased awareness. TED, linked to hyperthyroidism, causes eye ...

Eye discomfort and vision changes can sometimes signal deeper health issues. Understanding these signs early may help protect ...

Thyroid disorders can affect eye health in multiple ways. Learn why regular eye check-ups are essential, the symptoms of ...

Teresa Sanchez was in Mexico for a medical procedure nearly four years ago when she kept feeling dry, poking sensations in her right eye. She chalked it up to a potential rip in her contact lens, the ...

Active TED patients showed higher thyrotropin receptor antibody levels and increased DCP vessel density.

Dry eye disease affects millions of people, causing burning, redness, and constant eye fatigue that can worsen over time. Scientists now believe the problem may begin deep inside tear glands, where a ...

Dec 31 (Reuters) - Outlook Therapeutics (OTLK.O), opens new tab said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, dealing another blow in the ...

Twenty-two percent of African-American adults ages 40 and older with eye disease in a cross-sectional study had undetected eye disease. Diabetic retinopathy (82%) and age-related macular degeneration ...

TED is an autoimmune disorder distinct from Graves disease, affecting individuals with varying thyroid states and often misdiagnosed, especially in women. Symptoms of TED, such as pain and double ...

(RTTNews) - Argenx SE (ARGX ARGX.BR) announced on Monday that it is discontinuing its Phase 3 UplighTED studies evaluating Efgartigimod PH20 SC in adults with moderate to severe thyroid eye disease, ...

Argenx SE shares fell the most in seven months after the biotech firm said it will discontinue late-stage trials for an experimental medicine to treat an autoimmune disease affecting the eyes.

The company’s lead candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves’ disease and thyroid eye disease. Yarrow ...